Daytime : Actualité Daytime en direct - P1 | Bourse Reflex
Accueil > Tags > Daytime

  • Toutes les actualités en rapport avec « Daytime »

02/05 07:30 Daytime - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

02/05 07:30 Daytime - PRÉSENTATION ORALE DE THERANEXUS LORS DU 9ÈME CONGRÈS EUROPÉEN SUR LA NARCOLEPSIE LES 5 ET 6 MAI À MONTPELLIER

26/04 18:00 Daytime - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

26/04 18:00 Daytime - THERANEXUS ANNONCE SES RESULTATS ANNUELS 2017 ET PRESENTE UN POINT D'ACTUALITE CONCERNANT L'AVANCEE DE SES ESSAIS CLINIQUES

23/04 07:30 Daytime - LE THN102 OBTIENT LE STATUT D'INVESTIGATIONAL NEW DRUG DE LA FOOD AND DRUG ADMINISTRATION (FDA)

23/04 07:30 Daytime - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Daytime - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 18:00 Daytime - THERANEXUS ANNONCE L'OBTENTION D'UNE PREMIERE AUTORISATION EUROPEENNE POUR L'ETUDE CLINIQUE DE PHASE 2 AVEC THN102 DANS LA MALADIE DE PARKINSON

28/09 07:30 Daytime - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

30/03 18:00 Daytime - 2016 annual financial results and next development steps in 2017

13/10 18:00 Daytime - Quantum Genomics announces 2016 first-half financial results and first nine months business update

29/09 17:45 Daytime - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension